BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 2511818)

  • 41. [Study of "lupus-type" anticoagulant using diluted Russell's viper venom time. Study of 16 patients].
    Pardo Vigo A; Oteyza JP; Blanco L; Correa MA; César J; Avello AG; Frade JG; Navarro JL
    Sangre (Barc); 1987; 32(2):231-5. PubMed ID: 3112970
    [No Abstract]   [Full Text] [Related]  

  • 42. The frequency of lupus anticoagulant in systemic lupus erythematosus. A study of sixty consecutive patients by activated partial thromboplastin time, Russell viper venom time, and anticardiolipin antibody level.
    Petri M; Rheinschmidt M; Whiting-O'Keefe Q; Hellmann D; Corash L
    Ann Intern Med; 1987 Apr; 106(4):524-31. PubMed ID: 3103510
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Lupus Anticoagulant Testing: Diluted Russell Viper Venom Time (dRVVT).
    Pengo V; Bison E; Banzato A; Zoppellaro G; Jose SP; Denas G
    Methods Mol Biol; 2017; 1646():169-176. PubMed ID: 28804828
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Anti-factor VIII inhibitors and lupus anticoagulants in haemophilia A patients.
    Blanco AN; Cardozo MA; Candela M; Santarelli MT; Pérez Bianco R; Lazzari MA
    Thromb Haemost; 1997 Apr; 77(4):656-9. PubMed ID: 9134638
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Lupus anticoagulants: diagnostic dilemma and clinical challenge.
    Triplett DA
    Clin Lab Sci; 1997; 10(4):223-8. PubMed ID: 10169622
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The laboratory heterogeneity of lupus anticoagulants.
    Triplett DA; Brandt JT; Maas RL
    Arch Pathol Lab Med; 1985 Oct; 109(10):946-51. PubMed ID: 3929747
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Comparison of laboratory tests used for identification of the lupus anticoagulant.
    Lo SC; Oldmeadow MJ; Howard MA; Firkin BG
    Am J Hematol; 1989 Apr; 30(4):213-20. PubMed ID: 2494883
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The Ecarin time is an improved confirmatory test for the Taipan snake venom time in warfarinized patients with lupus anticoagulants.
    Moore GW; Smith MP; Savidge GF
    Blood Coagul Fibrinolysis; 2003 Apr; 14(3):307-12. PubMed ID: 12695757
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Heterogeneity of Russell's viper venom affects the sensitivity of the dilute Russell's viper venom time to lupus anticoagulants.
    Moore GW; Savidge GF
    Blood Coagul Fibrinolysis; 2004 Apr; 15(3):279-82. PubMed ID: 15060428
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The dilution effect of equal volume mixing studies compromises confirmation of inhibition by lupus anticoagulants even when mixture specific reference ranges are applied.
    Moore GW; Savidge GF
    Thromb Res; 2006; 118(4):523-8. PubMed ID: 16263154
    [TBL] [Abstract][Full Text] [Related]  

  • 51. A hexagonal (II) phase phospholipid neutralization assay for lupus anticoagulant identification.
    Triplett DA; Barna LK; Unger GA
    Thromb Haemost; 1993 Nov; 70(5):787-93. PubMed ID: 8128436
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Lupus anticoagulants.
    Shapiro SS; Thiagarajan P
    Prog Hemost Thromb; 1982; 6():263-85. PubMed ID: 6820164
    [No Abstract]   [Full Text] [Related]  

  • 53. Recombinant thromboplastin inhibition assay for the detection of lupus anticoagulant.
    Zanon E; Saracino MA; Simioni P; Scarano L; Girolami B; Girolami A
    Clin Lab Haematol; 1995 Sep; 17(3):231-5. PubMed ID: 8719896
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Lupus anticoagulants in children.
    Singh AK; Rao KP; Kizer J; Lazarchick J
    Ann Clin Lab Sci; 1988; 18(5):384-7. PubMed ID: 3140708
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Evaluation of sensitivity and specificity of confirmatory assays for lupus anticoagulant (LA) detection].
    Imoto K; Yasumuro Y; Taki M; Suzuki Y; Akatu S; Tajima C; Ichikawa Y
    Rinsho Byori; 1996 Aug; 44(8):797-801. PubMed ID: 8816068
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The automated modified Russell viper venom time test for the lupus anticoagulant.
    Petri M; Nelson L; Weimer F; Anderson D; Darlington T; Corash L
    J Rheumatol; 1991 Dec; 18(12):1823-5. PubMed ID: 1795319
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Distinguishing plasma lupus anticoagulants from anti-factor antibodies using hexagonal (II) phase phospholipids.
    Rauch J; Tannenbaum M; Janoff AS
    Thromb Haemost; 1989 Nov; 62(3):892-6. PubMed ID: 2512678
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The role of lipids in the detection of lupus anticoagulant by the dilute Russell Viper venom test: are platelets or reagents containing hexagonal HII phases necessary?
    Stevenson KJ; Seddon JM
    Br J Haematol; 1994 Mar; 86(3):583-9. PubMed ID: 8043440
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Improved detection of lupus anticoagulants by the dilute Russell's Viper venom time.
    Moore GW; Savidge GF; Smith MP
    Blood Coagul Fibrinolysis; 2000 Dec; 11(8):767-74. PubMed ID: 11132656
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Evaluation of a new commercial dilute prothrombin time in the diagnosis of lupus anticoagulants.
    Devreese KM
    Thromb Res; 2008; 123(2):404-11. PubMed ID: 18495217
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.